PULSE BIOSCIENCES, INC. — Director's Dealing 2024

Jun 25, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2024-06-06

Reporting Person: Zanganeh Mahkam (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-06	Stock Option (right to buy)	$14.55	A	20000	Acquired	2034-06-06	Common Stock (20000)	Direct
2024-06-06	Stock Option (right to buy)	$14.55	A	8247	Acquired	2034-06-06	Common Stock (8247)	Direct

Footnotes

F1: The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 6, 2024.

F2: The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2024.